Computational methods for the prediction of 'drug-likeness'

Drug Discovery Today

Volumn 5, Issue 2, 2000, Pages 49-58

  Clark, David E ^a   Pickett, Stephen D ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRENOLOL; ATENOLOL; CARBAMAZEPINE; CIPROFLOXACIN; DIAZEPAM; ENALAPRILAT; FLUINDOSTATIN; FOSCARNET; HYDROCHLOROTHIAZIDE; KETOPROFEN; LACTULOSE; MANNITOL; METOLAZONE; METOPROLOL; NITROGEN; NORDAZEPAM; OLSALAZINE; OXAZEPAM; OXPRENOLOL; OXYGEN; PHENAZONE; PINDOLOL; PRACTOLOL; RAFFINOSE; SALAZOSULFAPYRIDINE; SULPIRIDE; TERBUTALINE; TRANEXAMIC ACID; UNINDEXED DRUG; VERAPAMIL;

ALGORITHM; ARTIFICIAL NEURAL NETWORK; BLOOD BRAIN BARRIER; CHEMISTRY; DRUG DISTRIBUTION; DRUG INDUSTRY; EXCRETION; HUMAN; INTESTINE ABSORPTION; LIPOPHILICITY; METABOLISM; NONHUMAN; REVIEW; SCREENING; TECHNIQUE;

EID: 0033981358     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(99)01451-8     Document Type: Review

References (56)

1. Smith D.A., van de Waterbeemd H. Pharmacokinetics and metabolism in early drug discovery. Curr. Opin. Chem. Biol. 3:1999;373-378.
2. Delie F., Rubas W.A. A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: Advantages and limitations of the Caco-2 model. Crit. Rev. Ther. Drug Carrier Syst. 14:1997;221-286.
3. Irvine J.et al. MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening. J. Pharm. Sci. 88:1999;28-33.
4. Eddershaw P.J., Dickins M. Advances in in vitro drug metabolism screening. Pharm. Sci. Technol. Today. 2:1999;13-19.
5. Walters W.P.et al. Recognizing molecules with drug-like properties. Curr. Opin. Chem. Biol. 3:1999;384-387.
6. Lewis R.A.et al. Similarity measures for rational set selection and analysis of combinatorial libraries: The diverse property-derived (DPD) approach. J. Chem. Inf. Comput. Sci. 37:1997;599-614.
7. Rishton G.M. Reactive compounds and in vitro false positives in HTS. Drug Discovery Today. 2:1997;382-384.
8. Walters W.P.et al. Virtual screening - An overview. Drug Discovery Today. 3:1998;160-178.
9. Hann M.et al. Strategic pooling of compounds for high-throughput screening. J. Chem. Inf. Comput. Sci. 39:1999;897-902.
10. Gillet V.J.et al. Identification of biological activity profiles using substructural analysis and genetic algorithms. J. Chem. Inf. Comput. Sci. 38:1998;165-179.
11. Ajayet al. Can we learn to distinguish between drug-like and non-drug-like molecules? J. Med. Chem. 41:1998;3314-3324.
12. Sadowski J., Kubinyi H. A scoring scheme for discriminating between drugs and nondrugs. J. Med. Chem. 41:1998;3325-3329.
13. Polinsky A. Combichem and cheminformatics. Curr. Opin. Drug Discovery Dev. 2:1999;197-203.
14. Navia M.A., Chaturvedi P.R. Design principles for orally bioavailable drugs. Drug Discovery Today. 1:1996;179-189.
15. Chan O.H., Stewart B.H. Physicochemical and drug-delivery considerations for oral drug bioavailability. Drug Discovery Today. 1:1996;461-473.
16. Krämer, S.D. (1999) Absorption prediction from physicochemical parameters. Pharm. Sci. Technol. Today 2, 373-380; 2, 426 (corrigendum).
17. Krämer, S.D. (1999) Absorption prediction from physicochemical parameters. Pharm. Sci. Technol. Today 2, 373-380; 2, 426 (corrigendum).
18. Lipinski C.A.et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23:1997;3-25.
19. Moriguchi I.et al. Simple method of calculating octanol/water partition coefficient. Chem. Pharm. Bull. 40:1992;127-130.
20. Ghose A.K.et al. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J. Comb. Chem. 1:1999;55-68.
21. van de Waterbeemd H.et al. Estimation of Caco-2 cell permeability using calculated molecular descriptors. Quant. Struct.-Act. Relatsh. 15:1996;480-490.
22. Norinder U.et al. Theoretical calculation and prediction of Caco-2 cell permeability using MolSurf parametrization and PLS statistics. Pharm. Res. 14:1997;1786-1791.
23. Conradi R.A.et al. The influence of peptide structure on transport across Caco-2 cells. II. Peptide bond modification which results in improved permeability. Pharm. Res. 9:1992;435-439.
24. Palm K.et al. Correlation of drug absorption with molecular surface properties. J. Pharm. Sci. 85:1996;32-39.
25. Krarup L.H.et al. Predicting drug absorption from molecular surface properties based on molecular dynamics simulations. Pharm. Res. 15:1998;972-978.
26. Palm K.et al. Evaluation of dynamic polar molecular surface area as predictor of drug absorption: Comparison with other computational and experimental predictors. J. Med. Chem. 41:1998;5382-5392.
27. Stenberg P.et al. Prediction of membrane permeability to peptides from calculated dynamic molecular surface properties. Pharm. Res. 16:1999;205-212.
28. Palm K.et al. Polar molecular surface properties predict the intestinal absorption of drugs in humans. Pharm. Res. 14:1997;568-571.
29. Norinder U.et al. Theoretical calculation and prediction of intestinal absorption of drugs in humans using MolSurf parametrization and PLS statistics. Eur. J. Pharm. Sci. 8:1999;49-56.
30. Ghuloum A.M.et al. Molecular hashkeys: A novel method for molecular characterization and its application for predicting important pharmaceutical properties of molecules. J. Med. Chem. 42:1999;1739-1748.
31. Wessel M.D.et al. Prediction of human intestinal absorption of drug compounds from molecular structure. J. Chem. Inf. Comput. Sci. 38:1998;726-735.
32. Clark D.E. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption. J. Pharm. Sci. 88:1999;807-814.
33. Winiwarter S.et al. Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach. J. Med. Chem. 41:1998;4939-4949.
34. van de Waterbeemd H.et al. Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors. J. Drug Targeting. 6:1998;151-165.
35. Goodwin J.T.et al. Strategies toward predicting peptide cellular permeability from computed molecular descriptors. J. Pept. Res. 53:1999;355-369.
36. Raevsky O.A., Schaper K.-J. Quantitative estimation of hydrogen bond contribution to permeability and absorption processes of some chemicals and drugs. Eur. J. Med. Chem. 33:1998;799-807.
37. Pardridge W.M. CNS drug design based on principles of blood-brain barrier transport. J. Neurochem. 70:1998;1781-1792.
38. Cecchelli R.et al. In vitro model for evaluating drug transport across the blood-brain barrier. Adv. Drug Deliv. Rev. 36:1999;165-178.
39. de Lange E.C.M.et al. Microdialysis for pharmacokinetic analysis of drug transport to the brain. Adv. Drug Deliv. Rev. 36:1999;211-227.
40. George A. The design and molecular modeling of CNS drugs. Curr. Opin. Drug Discovery Dev. 2:1999;286-292.
41. Basak S.C.et al. Predicting blood-brain transport of drugs: A computational approach. Pharm. Res. 13:1996;775-778.
42. Fischer H.et al. Blood-brain barrier permeation: Molecular parameters governing passive diffusion. J. Membr. Biol. 165:1998;201-211.
43. Abraham M.H.et al. On the partition of ampholytes: Application to blood-brain distribution. J. Pharm. Sci. 86:1997;310-315.
44. van de Waterbeemd H., Kansy M. Hydrogen-bonding capacity and brain penetration. Chimia. 46:1992;299-303.
45. Calder J.A., Ganellin C.R. Predicting the brain-penetrating capability of histaminergic compounds. Drug Des. Discov. 11:1994;259-268.
46. Abraham M.H.et al. Hydrogen bonding. 33. Factors that influence the distribution of solutes between blood and brain. J. Pharm. Sci. 83:1994;1257-1268.
47. Platts J.A.et al. Estimation of molecular free energy relation descriptors using a group contribution approach. J. Chem. Inf. Comput. Sci. 39:1999;835-845.
48. Lombardo F.et al. Computation of brain-blood partitioning of organic solutes via free energy calculations. J. Med. Chem. 39:1996;4750-4755.
49. Norinder U.et al. Theoretical calculation and prediction of brain-blood partitioning of organic solutes using MolSurf parametrization and PLS statistics. J. Pharm. Sci. 87:1998;952-959.
50. Luco J.M. Prediction of the brain-blood distribution of a large set of drugs from structurally derived descriptors using partial least-squares (PLS) modeling. J. Chem. Inf. Comput. Sci. 39:1999;396-404.
51. Clark D.E. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration. J. Pharm. Sci. 88:1999;815-821.
52. Pickett, S.D. et al. Enhancing the hit-to-lead properties of lead optimization libraries. J. Chem. Inf. Comput. Sci. (in press).
53. Gratton J.A.et al. Molecular factors influencing drug transfer across the blood-brain barrier. J. Pharm. Pharmacol. 49:1997;1211-1216.
54. Habgood M.D.et al. Investigation into the correlation between the structure of hydroxypyridinones and blood-brain barrier permeability. Biochem. Pharmacol. 57:1999;1305-1310.
55. Ertl P. World Wide Web-based system for the calculation of substituent parameters and substituent similarity searches. J. Mol. Graph. Model. 16:1998;11-13.
56. Weininger D. SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules. J. Chem. Inf. Comput. Sci. 28:1988;31-36.